• AZD-3463: Advanced ALK/IGF1R Inhibition Strategies in Neurob

  2026-05-15

  Explore how AZD-3463, a potent ALK/IGF1R inhibitor, is reshaping neuroblastoma research with novel mechanisms and enhanced combination therapies. This article delivers deep scientific insight and practical assay guidance beyond existing resources.

• Bestatin Probes Jasmonate Signaling via Chemical Genetics in

  2026-05-14

  The referenced study demonstrates how bestatin, an aminopeptidase inhibitor, serves as a precise chemical tool to dissect jasmonate signaling pathways in Arabidopsis. Its approach uncovers new molecular components and regulatory nodes in plant defense and development, offering a model for chemical genetics in plant biology.

• TAK-242 (Resatorvid): Rethinking TLR4 Inhibition in Translat

  2026-05-14

  This article explores the mechanistic underpinnings and strategic deployment of TAK-242 (Resatorvid) for translational researchers focused on inflammatory disease and neuroinflammation. By bridging recent discoveries in pathogen-host interactions and TLR4 signaling, we offer actionable guidance on optimizing TAK-242 use, contextualize its place in the evolving competitive landscape, and delineate its translational promise and limitations.

• Captopril: ACE Inhibition Benchmarks, Protocols, and Evidenc

  2026-05-13

  Captopril is a potent ACE inhibitor with high specificity (IC50 6 nM), widely used in hypertension and cancer research. This article details its verifiable biological rationale, mechanism, and protocol parameters, supporting reproducible workflows in cardiovascular and oncology studies.

• Efficient Synthesis of Deuterium-Labeled Degarelix Acetate

  2026-05-13

  This study reports a practical 13-step route for synthesizing deuterium-labeled degarelix acetate, a critical internal standard for pharmacokinetic and metabolic studies of GnRH receptor antagonists. The work advances the field by enabling robust isotope-labeled standards, supporting clinical research in androgen-related diseases and drug metabolism.

• Sulfaphenazole: Modernizing Antibacterial and CYP2C9 Inhibit

  2026-05-12

  Explore the dual role of Sulfaphenazole as a selective CYP2C9 inhibitor and antibacterial agent. This in-depth analysis reveals unique insights into assay optimization, resistance challenges, and evolving applications in drug metabolism and infectious disease research.

• Applied Workflows for JNJ-26854165 (Serdemetan) in Cancer Re

  2026-05-12

  JNJ-26854165 (Serdemetan) excels as a robust HDM2 inhibitor and p53 pathway modulator, empowering researchers to dissect anti-proliferative and apoptosis mechanisms in p53 wild-type tumor models. This guide delivers actionable protocols, troubleshooting strategies, and advanced insights for radiosensitization and precision oncology workflows.

• Gut-Brain Cholinergic Signaling in B. fragilis-Mediated Seiz

  2026-05-11

  Jia et al. identify a gut-brain cholinergic pathway by which Bacteroides fragilis suppresses seizures, mediated through vagal activation and enhanced acetylcholine signaling. Their work establishes a mechanistic microbiota-neural circuit link and demonstrates clinical relevance in pediatric refractory epilepsy.

• Isoprinosine (Inosine Pranobex): Mechanism, Evidence & Appli

  2026-05-11

  Isoprinosine (inosine pranobex) is a crystalline immunomodulatory agent that inhibits viral replication and enhances immune responses. Clinical and preclinical data support its efficacy, especially in acute respiratory viral infections. Mechanistic studies reveal both direct antiviral effects and immunopotentiation, with a favorable safety profile.

• Neuroinflammation Drives Mechanical Allodynia via Ca2+-Piezo

  2026-05-10

  Liao et al. reveal a novel Ca2+-dependent neuroinflammatory feedback loop involving the CGRP/SP-Piezo2 axis in trigeminal neuralgia. Their integrative study links ATP-driven signaling, mechanotransduction, and protein kinase modulation as central to orofacial mechanical allodynia, offering new mechanistic insight and experimental approaches.

• Defined Culture Improves Human Intestinal Organoid Modeling

  2026-05-09

  Capeling's dissertation demonstrates that precisely defined culture environments significantly enhance human intestinal organoid (HIO) systems, providing improved reproducibility and physiological relevance for the study of intestinal development. This work clarifies the roles of pluripotent stem cell maintenance and differentiation pathways in organoid generation, informing best practices for future translational and developmental research.

• AR Heterogeneity Drives Divergent Prostate Cancer Drug Respo

  2026-05-09

  This study reveals that androgen receptor (AR) expression heterogeneity in prostate cancer underlies distinct responses to castration and enzalutamide therapy. By dissecting AR+/hi and AR−/lo cell populations, the authors establish BCL-2 as a therapeutic target and propose tailored strategies for overcoming treatment resistance.

• AMPK Regulates Mitophagy-Inflammation Crosstalk in Diabetic

  2026-05-08

  This study demonstrates that AMPK activation orchestrates the interplay between PINK1/Parkin-mediated mitophagy and NLRP3-driven inflammation in periodontal ligament fibroblasts under mechanical loading, especially in diabetic conditions. The findings suggest targeting AMPK as a promising strategy to mitigate inflammation and preserve periodontal tissue homeostasis.

• Arctigenin (SKU N2399): Reliable Cell Assay Performance

  2026-05-07

  This evidence-driven guide addresses recurring laboratory challenges in cell viability, proliferation, and cytotoxicity assays. Leveraging the mechanistic specificity of Arctigenin (SKU N2399), we contextualize its performance within real experimental workflows and compare it to alternative sources. Researchers gain actionable insights on protocol optimization, reproducibility, and data interpretation, all anchored by current literature and validated sourcing from APExBIO.

• 4-Ethylphenyl Sulfate in Gut-Brain and Renal Biomarker Assay

  2026-05-07

  Harness the translational power of 4-ethylphenyl sulfate—a validated microbiota-derived metabolite—in both gut-brain interaction research and renal dysfunction biomarker studies. This article delivers actionable workflows, protocol optimizations, and troubleshooting rooted in adsorption science and APExBIO’s high-purity compound, ensuring reproducible results in neurobehavioral and biomaterial assays.

450 records 18/30 page Previous Next First page 上5页 1617181920 下5页 Last page